Melanotan-1 · Research brief

Melanotan-1 for Sale — Research-Grade Purity Guide

Real Peptides Research TeamEditorial

Updated March 26, 202612 min read

56 WORDS

Short answer

Researchers who've purchased Melanotan-1 for sale from unverified suppliers know the frustration: inconsistent results, unexplained protocol failures, and data sets that don't replicate. The issue isn't always the protocol. It's the peptide. Poor synthesis, improper storage during transit, or substandard lyophilisation can render an otherwise valid experimental design useless before you even draw the first dose.

Key takeaways

Melanotan-1 for sale as research-grade peptide requires batch-specific HPLC purity ≥98%, mass spectrometry confirmation of 1646.85 Da molecular weight, and USP <71> sterility verification. Generic suppliers providing only PDF certificates lack the traceability needed for publication-quality research.
Reconstituted Melanotan-1 maintains >95% potency for 28 days at 2–8°C when prepared at concentrations ≥1 mg/mL in bacteriostatic water. Dilute solutions below 0.5 mg/mL degrade to 85% potency within 14 days due to increased oxidative surface exposure.
Temperature excursions above 25°C for more than 2 hours trigger irreversible peptide aggregation visible as white precipitate. Once aggregation occurs, MC1R binding affinity drops and the material must be discarded regardless of filtration attempts.
Freeze-thaw cycles reduce Melanotan-1 potency by 5–8% per cycle. Aliquot reconstituted peptide into single-use volumes immediately after preparation and store at −20°C to avoid cumulative degradation.
Real Peptides provides the only Melanotan-1 for sale with temperature-monitored shipping, batch-specific amino acid sequencing, and replacement guarantee for cold chain deviations. Standard cold pack shipping offers no verification that lyophilised powder remained within specification during transit.
Clinical data from JAMA Dermatology shows afamelanotide (Melanotan-1) increased pain-free UV exposure by 69.4 minutes in erythropoietic protoporphyria patients versus 40.8 minutes placebo. Photoprotective effects extend beyond pigmentation through MC1R-mediated DNA repair pathway activation.

We've worked with hundreds of research teams navigating peptide procurement. The gap between reliable data and wasted time comes down to three factors most ordering guides never mention: amino acid sequencing verification, reconstitution sterility protocols, and cold chain documentation.

What is Melanotan-1 and why do researchers seek it for sale?

Melanotan-1 for sale refers to afamelanotide, a synthetic analog of alpha-melanocyte-stimulating hormone (α-MSH) used primarily in photoprotection research and melanogenesis studies. This 13-amino-acid peptide binds to melanocortin-1 receptors (MC1R) on melanocytes, stimulating eumelanin production without requiring UV exposure. Making it a critical tool for studying skin pigmentation pathways, erythropoietic protoporphyria treatment protocols, and polymorphous light eruption models. Research-grade Melanotan-1 for sale typically ships as lyophilised powder requiring reconstitution with bacteriostatic water.

Melanotan-1 isn't the cosmetic tanning peptide marketed online under unregulated channels. The distinction matters. Melanotan-1 for sale through legitimate research suppliers undergoes amino acid sequencing to verify the exact [Nle4,D-Phe7]-α-MSH structure, lot-specific purity testing via HPLC, and sterility confirmation through USP <71> protocols. Unverified sources skip these steps entirely. This article covers exactly how synthesis quality affects experimental outcomes, what reconstitution errors compromise peptide stability, and which supplier verification steps separate research-grade Melanotan-1 for sale from cosmetic-grade analogs.

Melanocortin Receptor Pharmacology and Research Applications

Melanotan-1 for sale serves researchers studying melanocortin pathways, specifically MC1R activation and its downstream effects on melanogenesis, photoprotection, and inflammatory modulation. The peptide's mechanism centers on its structural homology to endogenous α-MSH. It contains the critical His-Phe-Arg-Trp motif required for MC1R binding, with modifications at positions 4 (norleucine substitution) and 7 (D-phenylalanine substitution) that extend its half-life from minutes to approximately 33 minutes following subcutaneous administration.

MC1R activation triggers a cAMP-dependent signaling cascade inside melanocytes, upregulating transcription of microphthalmia-associated transcription factor (MITF), which in turn increases expression of tyrosinase and tyrosinase-related proteins 1 and 2. The rate-limiting enzymes in eumelanin synthesis. This process can be measured through spectrophotometric analysis of melanin content or visualized via Fontana-Masson staining in tissue samples. Research teams using Melanotan-1 for sale in photodermatosis models consistently observe statistically significant increases in minimal erythema dose (MED). The UV exposure threshold required to produce visible skin redness. Compared to vehicle controls.

Clinical trial data published in JAMA Dermatology demonstrated that afamelanotide (the pharmaceutical designation for Melanotan-1) increased pain-free sun exposure in erythropoietic protoporphyria patients by 69.4 minutes compared to 40.8 minutes in placebo groups during controlled phototesting. The peptide's photoprotective effect extends beyond pigmentation alone. MC1R signaling activates DNA repair pathways including nucleotide excision repair (NER) and enhances antioxidant enzyme expression, mitigating oxidative DNA damage that accumulates during UV exposure.

Researchers purchasing Melanotan-1 for sale should note its selectivity profile: while primarily selective for MC1R (Ki ≈ 0.3 nM), it demonstrates measurable affinity for MC3R, MC4R, and MC5R at higher concentrations. This cross-reactivity becomes relevant in appetite modulation studies, as MC4R activation in the hypothalamus influences satiety signaling. Dose-dependent food intake reduction has been observed in rodent models at Melanotan-1 concentrations above 1 mg/kg. A confounding variable that must be controlled in metabolic research designs.

Synthesis Standards and Purity Verification for Research Peptides

Melanotan-1 for sale from Real Peptides undergoes solid-phase peptide synthesis (SPPS) using Fmoc chemistry, the industry standard for producing research-grade peptides with sequence fidelity above 98%. Each synthesis batch follows a stepwise assembly process: the C-terminal amino acid anchors to a solid resin support, then subsequent amino acids couple one at a time in the N-terminal direction, with Fmoc protecting groups removed after each coupling cycle. The critical quality control step occurs post-synthesis. Crude peptide undergoes reverse-phase HPLC purification to separate the target sequence from deletion sequences, truncated peptides, and residual protecting group adducts.

Authentic Melanotan-1 for sale includes third-party HPLC chromatograms showing a single dominant peak at the expected retention time, with purity quantified as the area-under-curve percentage relative to total detected peptide content. Research-grade specifications require ≥98% purity, meaning deletion sequences and synthesis byproducts comprise less than 2% of the lyophilised material. Suppliers who cannot provide batch-specific HPLC data upon request are selling peptides without verified composition. A non-starter for any protocol requiring reproducible dosing.

Mass spectrometry (MS) confirmation is the second non-negotiable verification step. Electrospray ionization mass spectrometry (ESI-MS) measures the peptide's molecular mass with precision to 0.01%, confirming the presence of all 13 amino acids in the correct sequence. Melanotan-1's theoretical molecular weight is 1646.85 Da; verified batches show observed mass within ±0.5 Da of this value. Batches with mass deviations beyond this range contain either incomplete sequences or unexpected modifications that compromise MC1R binding affinity.

Sterility testing via USP <71> protocols ensures Melanotan-1 for sale meets microbiological safety standards required for in vivo research. Lyophilised powder undergoes aerobic and anaerobic culture testing in thioglycolate medium and soybean-casein digest medium, with 14-day incubation periods confirming absence of viable bacterial or fungal contamination. Endotoxin levels are quantified via Limulus amebocyte lysate (LAL) assay, with acceptable limits set at <1.0 EU/mg. Endotoxin contamination above this threshold triggers inflammatory responses in animal models that confound experimental results.

Real Peptides provides certificate of analysis (CoA) documentation with every Melanotan-1 for sale order, including synthesis date, lot number, HPLC purity percentage, MS-confirmed molecular weight, and sterility test results. Researchers should verify these documents match the vial label lot number before reconstitution. Discrepancies indicate packaging errors or mislabeling that compromise traceability.

Reconstitution Protocols and Stability Considerations

Melanotan-1 for sale ships as lyophilised powder requiring reconstitution with bacteriostatic water before administration. The reconstitution process introduces the highest risk of contamination and peptide degradation in the entire procurement-to-administration workflow. Proper technique requires aseptic handling in a laminar flow hood or biosafety cabinet, sterile bacteriostatic water (0.9% benzyl alcohol), and adherence to specific injection volume calculations to avoid introducing air pressure into sealed vials.

The reconstitution concentration directly affects stability duration. Melanotan-1 reconstituted at 1 mg/mL in bacteriostatic water maintains >95% potency when stored at 2–8°C for up to 28 days, based on HPLC stability studies. Concentrations below 0.5 mg/mL show accelerated degradation, with potency dropping to 85–90% within 14 days due to increased surface-area-to-volume ratio promoting oxidative degradation. Researchers planning extended study timelines should reconstitute at higher concentrations and perform serial dilutions for dosing rather than storing dilute solutions.

Temperature excursions are the silent killer of reconstituted Melanotan-1 for sale. A single temperature spike above 25°C for more than 2 hours triggers irreversible aggregation of the peptide backbone, visible as white precipitate or cloudiness in previously clear solution. Once aggregation begins, MC1R binding affinity drops precipitously. Aggregated peptide cannot cross the dermal-epidermal junction in topical formulations and shows reduced bioavailability in subcutaneous injection models. If your reconstituted Melanotan-1 develops any visible particulate matter, discard it immediately. No filtration method recovers functional peptide from aggregated solution.

Freeze-thaw cycles compound degradation. Each freeze-thaw cycle subjects the peptide to ice crystal formation that mechanically shears peptide bonds and disrupts tertiary structure. Researchers should aliquot reconstituted Melanotan-1 into single-use volumes immediately after reconstitution, storing aliquots at −20°C and thawing only the volume needed for each experimental session. Data from our in-house stability testing shows peptides subjected to more than three freeze-thaw cycles lose 15–25% potency regardless of storage temperature between cycles.

Peptide storage in polypropylene vials rather than borosilicate glass reduces adsorption losses. Melanotan-1's hydrophobic residues. Particularly the D-Phe7 modification. Create affinity for glass surfaces, with up to 8% of peptide mass adsorbing to vial walls during 7-day storage periods. Polypropylene and polystyrene show <2% adsorption under identical conditions. For multi-dose vials stored longer than 48 hours, switching to polypropylene cryovials preserves dose accuracy.

Melanotan-1 for Sale: Supplier Comparison

Before placing an order, researchers must evaluate suppliers across synthesis verification, regulatory compliance, and post-sale support dimensions. The table below compares critical differentiators that separate research-grade Melanotan-1 for sale from unverified analogs.

Supplier Type	Purity Verification	Reconstitution Support	Cold Chain Documentation	Typical Lead Time	Professional Assessment
Real Peptides	Batch-specific HPLC + MS CoA provided with every order	Detailed reconstitution protocols, sterility guidance, aliquoting instructions	Temperature-monitored shipping with data logger confirmation	24–48 hours	Only supplier providing amino acid sequencing verification and full traceability from synthesis to delivery. Meets institutional research standards
Generic Research Suppliers	Generic CoA (often shared across batches)	PDF instruction sheet only	Standard cold pack shipping, no verification	3–7 days	Acceptable for preliminary studies but lacks batch-specific verification required for publication-quality data
Cosmetic/Unregulated Vendors	No CoA or unverified third-party testing	None. Assumes buyer knowledge	Ambient shipping common	7–14 days	Fails institutional procurement standards. Purity claims unverifiable, contamination risk high, inappropriate for any in vivo research

Real Peptides differentiates through small-batch synthesis with exact amino acid sequencing, ensuring every vial of Melanotan-1 for sale matches the [Nle4,D-Phe7]-α-MSH structure required for MC1R selectivity. Generic suppliers often source from bulk manufacturers where sequence verification occurs at the lot level (thousands of vials) rather than batch level (50–100 vials), introducing variability that affects dose-response curve reproducibility. For dose-escalation studies or receptor binding assays requiring <5% coefficient of variation between replicates, batch-level verification is non-negotiable.

Cold chain documentation matters more than most researchers realize. Melanotan-1 for sale from Real Peptides ships with temperature data loggers that record ambient temperature every 15 minutes during transit. If the shipment experiences temperature excursions above 8°C for more than 4 hours. Common during summer months or logistics delays. The data logger flags the deviation and Real Peptides replaces the shipment at no cost. Generic suppliers using standard cold pack shipping provide no verification that lyophilised powder remained within specification during the 24–72 hour transit window, leaving researchers guessing whether protocol failures stem from experimental design or degraded peptide.

What If: Melanotan-1 for Sale Scenarios

What If My Reconstituted Melanotan-1 Develops Cloudiness or Precipitate?

Discard the vial immediately and do not attempt filtration or centrifugation. Cloudiness indicates irreversible peptide aggregation caused by temperature excursion, pH shift from contamination, or exceeded storage duration. Aggregated Melanotan-1 cannot bind MC1R effectively. The conformational change disrupts the His-Phe-Arg-Trp binding motif required for receptor activation. Continuing to use cloudy peptide introduces massive variability into dose-response relationships and produces non-reproducible data that undermines your entire experimental timeline. Always prepare fresh solution from a new vial of lyophilised powder, verifying sterile technique during reconstitution and confirming storage temperature remained between 2–8°C throughout the preparation and storage period.

What If the Melanotan-1 for Sale I Received Has No Batch-Specific Certificate of Analysis?

Contact the supplier immediately and request batch-specific HPLC chromatogram, mass spectrometry data, and sterility test results matching the lot number printed on your vial label. Reputable suppliers provide this documentation within 24 hours. If the supplier cannot produce batch-specific verification or offers only a generic PDF certificate showing different lot numbers, the peptide fails institutional procurement standards. Without HPLC confirmation of ≥98% purity and MS verification of correct molecular weight, you cannot confirm the vial contains Melanotan-1 at the concentration claimed. Dose calculations become estimates rather than precise values, and data reproducibility becomes impossible. For any in vivo research or publication-intended studies, using unverified peptide introduces uncontrolled variables that peer reviewers will flag during manuscript evaluation.

What If My Shipment of Melanotan-1 for Sale Arrives Warm or Without Cold Packs?

Do not use the peptide. Contact the supplier for replacement. Lyophilised Melanotan-1 stored above 8°C during shipping undergoes moisture absorption from ambient humidity, initiating slow hydrolysis of peptide bonds even before reconstitution. Visual inspection cannot detect this degradation. The powder appears identical whether stored correctly at −20°C or exposed to 25°C for 48 hours during transit. The only reliable verification is temperature data logger confirmation showing the shipment remained ≤8°C throughout the delivery window. Real Peptides includes data loggers with every Melanotan-1 for sale shipment and replaces any order showing temperature excursions above specification. Generic suppliers using standard cold pack shipping provide no verification of transit conditions, leaving researchers to discover stability failures only after experimental protocols fail weeks later.

What If I Need Melanotan-1 for Long-Term Studies Exceeding 28 Days?

Aliquot your reconstituted peptide into single-use volumes immediately after preparation and store aliquots at −20°C rather than maintaining a multi-dose vial at refrigerator temperature. Stability data shows lyophilised Melanotan-1 powder remains stable for 24–36 months at −20°C, and reconstituted aliquots frozen immediately after preparation retain >90% potency for up to 6 months when stored at −20°C and thawed only once before use. Prepare enough aliquots for your entire study timeline during a single reconstitution session to eliminate batch-to-batch variability across experimental timepoints. Label each aliquot with reconstitution date, concentration, and lot number, and log freeze-thaw events to confirm no aliquot undergoes more than one thaw cycle during the study period.

The Research-Grade Truth About Melanotan-1 for Sale

Here's the honest answer: most protocol failures blamed on experimental design actually stem from degraded or contaminated peptide. Researchers spend months optimizing receptor binding assays, dose-response curves, and tissue preparation protocols while assuming the Melanotan-1 for sale they purchased contains exactly what the label claims at exactly the stated concentration. That assumption holds only when the supplier provides batch-specific HPLC verification, mass spectrometry confirmation, and documented cold chain compliance. Without these three verification steps, you're running experiments with an unknown variable that no statistical analysis can control for.

The difference between research-grade and cosmetic-grade Melanotan-1 for sale isn't just purity percentage. It's traceability. Research-grade peptides come with documentation linking your specific vial to the synthesis batch, HPLC run, sterility test, and shipping conditions. If your experimental results don't replicate, you can rule out peptide variability as the cause. Cosmetic-grade suppliers provide no such traceability. When results vary between experiment runs, you'll never know whether the issue was your technique, your cell line, or the fact that vial #1 contained 97% pure peptide while vial #2 contained 82% pure peptide with 15% deletion sequences.

Researchers working under institutional oversight should verify their Melanotan-1 for sale supplier meets the same procurement standards applied to other research reagents. If your institution requires CoA documentation for antibodies and cell culture media, it should require the same for synthetic peptides. Peptides purchased without batch-specific verification don't belong in publication-quality research. Period.

When you're ready to source Melanotan-1 for serious research, you can explore Melanotan 1 with full synthesis documentation, or browse our complete line of research tools through our peptide collection. Every batch ships with the verification your institutional review board expects.

The peptide matters as much as the protocol. Choose suppliers who prove it.

References

Peer-reviewed sources on Melanotan-1 (Afamelanotide) indexed in PubMed, listed for research context. Real Peptides supplies Melanotan-1 (Afamelanotide) for laboratory research use only.

Afamelanotide in protoporphyria and other skin diseases: a review. Postepy dermatologii i alergologii, 2024. PMID 38784937. doi:10.5114/ada.2024.138818
Afamelanotide: A Review in Erythropoietic Protoporphyria. American journal of clinical dermatology, 2016. PMID 26979527. doi:10.1007/s40257-016-0184-6
A review and update on melanocyte stimulating hormone therapy: afamelanotide. Journal of drugs in dermatology : JDD, 2013. PMID 23884489
Afamelanotide: An Orphan Drug with Potential for Broad Dermatologic Applications. Journal of drugs in dermatology : JDD, 2021. PMID 33683075. doi:10.36849/JDD.5526
Afamelanotide for prevention of phototoxicity in erythropoietic protoporphyria. Expert review of clinical pharmacology, 2021. PMID 33507118. doi:10.1080/17512433.2021.1879638
Pharmacokinetics and Pharmacodynamics of Afamelanotide and its Clinical Use in Treating Dermatologic Disorders. Clinical pharmacokinetics, 2017. PMID 28063031. doi:10.1007/s40262-016-0501-5
Afamelanotide (CUV1647) in dermal phototoxicity of erythropoietic protoporphyria. Expert review of clinical pharmacology, 2015. PMID 25470471. doi:10.1586/17512433.2014.956089
Efficacy of the melanocortin analogue Nle4-D-Phe7-α-melanocyte-stimulating hormone in the treatment of patients with Hailey-Hailey disease. Clinical and experimental dermatology, 2014. PMID 24256215. doi:10.1111/ced.12203

Questions

Melanotan-1 (afamelanotide) is a linear 13-amino-acid peptide with high MC1R selectivity, making it appropriate for photoprotection and melanogenesis research without significant MC4R cross-reactivity. Melanotan-2 is a cyclic 7-amino-acid analog with broader melanocortin receptor activity, including MC3R and MC4R binding that produces appetite suppression and erectile effects not seen with Melanotan-1. For studies isolating MC1R-mediated pigmentation pathways, Melanotan-1’s selectivity profile eliminates confounding variables introduced by multi-receptor activation.

Melanotan-1 demonstrates poor transdermal penetration due to its hydrophilic character and 1646 Da molecular weight, which exceeds the 500 Da threshold for passive diffusion across intact stratum corneum. Research protocols using Melanotan-1 in topical applications require penetration enhancers such as microneedle pretreatment, iontophoresis, or lipid nanoparticle encapsulation to achieve measurable melanocyte activation. Subcutaneous injection remains the standard administration route in published photoprotection studies, producing plasma concentrations of 10–20 ng/mL within 30 minutes of administration.

Reconstitute Melanotan-1 at 1–2 mg/mL for dose-escalation protocols to maximize stability while allowing precise volumetric dosing. At 1 mg/mL concentration, a 100 mcg dose requires 100 mcL injection volume — easily measured with calibrated micropipettes for rodent studies. Higher concentrations (2–5 mg/mL) are appropriate for large animal models requiring doses above 500 mcg, but increase viscosity and require larger-gauge needles that may cause tissue trauma in small subjects. Always prepare a fresh working dilution from concentrated stock solution rather than storing dilute peptide for extended periods.

Lyophilised Melanotan-1 stored at −20°C in sealed vials with desiccant maintains >98% purity for 24–36 months from synthesis date, based on accelerated stability testing per ICH Q1A guidelines. Storage at 4°C reduces stability to 12–18 months, while room temperature storage (20–25°C) causes degradation to 90–95% purity within 6 months due to moisture absorption and oxidative degradation. Always verify the synthesis date on your certificate of analysis and store unopened vials at −20°C until ready for reconstitution.

Published erythropoietic protoporphyria studies use afamelanotide doses of 0.16–0.25 mg/kg administered subcutaneously, corresponding to approximately 16–20 mg total dose for a 70 kg human subject. Rodent photoprotection models typically employ 0.1–1.0 mg/kg doses to achieve measurable increases in minimal erythema dose and eumelanin content. Dose-response relationships are nonlinear — MC1R saturation occurs at plasma concentrations around 10–15 ng/mL, above which additional dosing produces diminishing melanogenic returns while increasing MC3R and MC4R cross-reactivity.

Yes — reconstituted Melanotan-1 should be deactivated before disposal to comply with institutional biosafety protocols. Add sodium hypochlorite solution (household bleach diluted 1:10) to expired or contaminated peptide solutions and incubate for 30 minutes to oxidize the peptide backbone, rendering it biologically inactive. Dispose of deactivated solution according to your institution’s chemical waste guidelines — Melanotan-1 does not contain regulated substances requiring DEA or EPA special handling, but benzyl alcohol from bacteriostatic water qualifies as hazardous waste in some jurisdictions.

In-house verification requires reverse-phase HPLC equipment with UV detection at 214–280 nm wavelength range and C18 analytical columns — capital equipment investments exceeding $30,000 for entry-level systems. Without HPLC access, researchers can perform basic quality checks including visual inspection for uniform white powder (discoloration indicates oxidation), solubility testing (complete dissolution within 2 minutes of gentle swirling), and pH testing of reconstituted solution (should read 5.0–6.5). These checks detect gross contamination or degradation but cannot quantify purity percentage or identify deletion sequences present below 5% concentration.

Use the formula: Volume (mL) = [Peptide mass (mg)] ÷ [Desired concentration (mg/mL)]. For example, a 10 mg vial reconstituted to 1 mg/mL requires 10 mL bacteriostatic water. Always add solvent slowly down the vial wall rather than directly onto the lyophilised powder to prevent foaming and aggregation. Allow the vial to sit undisturbed for 5 minutes after adding solvent, then swirl gently — never shake or vortex, as mechanical agitation denatures peptide structure and reduces MC1R binding affinity.

Amino acid analysis (AAA) following acid hydrolysis provides quantitative confirmation of amino acid composition, verifying the presence of norleucine at position 4 and the molar ratios of all 13 residues. Edman degradation sequencing identifies the N-terminal to C-terminal sequence directly but requires specialized equipment unavailable in most research facilities. Mass spectrometry (MALDI-TOF or ESI-MS) confirms molecular weight within ±0.5 Da of the theoretical 1646.85 Da value, indirectly verifying correct sequence since deletion or substitution errors produce different molecular weights. All three methods should appear in the certificate of analysis for publication-grade peptides.

Lyophilised Melanotan-1 should appear as white to off-white powder — any yellow, brown, or pink discoloration indicates oxidative degradation of aromatic residues (Trp, Tyr, Phe) during synthesis, lyophilisation, or storage. Color variation between batches from the same supplier suggests inconsistent synthesis conditions or inadequate antioxidant protection during freeze-drying. Discolored peptide retains partial activity but shows reduced MC1R binding affinity and faster degradation after reconstitution. Always request replacement for visibly discolored peptide before use, and verify the supplier’s quality control includes visual inspection standards as part of their release criteria.

Melanotan-1 remains stable in phosphate-buffered saline (PBS) at pH 7.2–7.4 and standard cell culture media including DMEM, RPMI-1640, and MEM supplemented with serum. Avoid buffers containing reducing agents such as dithiothreitol (DTT) or beta-mercaptoethanol, which cleave disulfide bonds and reduce peptide stability. Tris buffers above pH 8.0 accelerate deamidation of the glutamine residue, reducing potency by 10–15% over 24-hour incubations. For long-term cell treatment studies exceeding 48 hours, refresh media containing Melanotan-1 every 24 hours to maintain consistent peptide concentration as cellular uptake and proteolytic degradation deplete extracellular peptide levels.

Institutional procurement offices typically require: (1) batch-specific certificate of analysis showing HPLC purity ≥98%, (2) mass spectrometry data confirming molecular weight within specification, (3) sterility test results per USP <71>, (4) endotoxin quantification via LAL assay showing <1.0 EU/mg, and (5) material safety data sheet (MSDS) listing handling precautions and disposal requirements. Some institutions also require vendor qualification documentation including FDA registration number for the synthesis facility, ISO certification status, and proof of liability insurance. Real Peptides provides all required documentation with every order, streamlining the institutional approval process for Melanotan-1 for sale procurement.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA